Form 4: Regencell Director Sells 19,000 Stock Options to Company

Regencell Bioscience Holdings Ltd Director Evana Yee Wah Hui sold 19,000 stock options back to the company at $15.00 per option.

Summary

• Evana Yee Wah Hui, a Director and 10% Owner of Regencell Bioscience Holdings Ltd (RGC), reported a transaction.
• On May 27, 2026, the Issuer repurchased options to purchase 19,000 ordinary shares from the Reporting Person.
• The repurchase price was $15.00 per option.
• The exercise price of these options was $0.25 per share, adjusted for previous share split(s).
• The aggregate consideration payable to the Reporting Person is reduced by the aggregate exercise price of the repurchased options.
• Following this transaction, the Reporting Person beneficially owns 573,230 derivative securities (stock options).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event for the company due to reduced potential dilution, balanced by the cash outflow for the repurchase. For the insider, it's a positive liquidity event.

Positives

• The company's repurchase of 19,000 stock options reduces potential future share dilution.
• The reporting person received $15.00 per option, providing liquidity for their holdings.

Negatives

• The company incurred a cash outflow to repurchase the options at $15.00 per option, significantly above the $0.25 exercise price.
• The reporting person reduced their direct equity exposure to the company by selling these options.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategy.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into how company executives and significant shareholders are managing their equity stakes. This specific transaction, an option repurchase by the company from a director, is a direct equity management action rather than a reflection of broader industry trends.

Related Party Transactions

• The repurchase of stock options by the Issuer from Evana Yee Wah Hui, a Director and 10% Owner, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Potential reduction in future share dilution, but also a cash outflow from the company.
• Reporting Person (Evana Yee Wah Hui): Received cash consideration for the options, reducing her direct equity exposure.

Key Dates

Keywords

Regencell Bioscience, RGC, Form 4, Insider Transaction, Stock Options, Option Repurchase, Director Sale, Beneficial Ownership